Dar Zavain 4/A
4/A · RECURSION PHARMACEUTICALS, INC. · Filed Apr 28, 2023
Insider Transaction Report
Form 4/AAmended
Dar Zavain
Director
Transactions
- Award
Class A Common Stock
2023-04-03+1,996→ 57,569 total
Footnotes (2)
- [F1]The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.
- [F2]Includes a total of 35,008 shares received pursuant to a pro-rata distribution from Lux Ventures, of which the Reporting Person was a limited partner. The acquisition of such shares was exempt pursuant to Rule 16a-9 and was inadvertently excluded from the total amount of shares held on the original Form 4 filing.